Related Experiment Video
Updated: Aug 3, 2026

Assessing Therapeutic Angiogenesis in a Murine Model of Hindlimb Ischemia
Published on: June 8, 2019
Three cases of digital ischemia successfully treated with cilostazol
Insights
Cilostazol effectively treated severe digital ischemia in three patients, resolving pain and restoring circulation. This medication, typically for intermittent claudication, showed promise for refractory cases.
Area of Science:
- Vascular Medicine
- Pharmacology
Background:
- Digital ischemia presents a significant clinical challenge, often refractory to standard treatments.
- Limited therapeutic options exist for severe cases impacting quality of life.
Observation:
- Three patients with refractory digital ischemia (post-traumatic, CREST syndrome, arterial thrombosis) were assessed.
- Conventional therapies including vasodilators and anticoagulation failed to resolve symptoms.
Findings:
- Cilostazol administration led to symptom resolution in all three patients.
- Improved digital perfusion was confirmed by plethysmography post-treatment.
- Digital ulcerations, pain, and cyanosis resolved within 4-8 weeks of cilostazol initiation.
Implications:
- Cilostazol demonstrates potential efficacy in managing severe digital ischemia beyond its approved indication.
- This suggests a broader therapeutic role for cilostazol in ischemic conditions.
- Further research is warranted to explore cilostazol's mechanism in digital ischemia.
Abstract:
Three patients were evaluated for refractory digital ischemia. The first patient presented with chronic, post-traumatic, unremitting, cold, painful, right fourth and fifth fingers. The symptoms had failed to improve despite topical nitroglycerin and a calcium channel blocker. Baseline digital plethysmography documented impaired perfusion within the affected digits. Cilostazol (Pletal) was added to the medical regimen and at the 8-week follow-up the fourth and fifth fingers were warm with repeat plethysmography displaying normal perfusion. A second patient had CREST syndrome-associated painful bilateral index finger ulcerations that had evolved despite taking a calcium channel blocker. Consequently the patient was started on cilostazol and within 4 weeks the digital ulcerations and pain had resolved. The third patient with traumatic right fifth digital arterial thrombosis was seen for persistent pain and cyanosis in spite of undergoing thrombolysis and subsequent anticoagulation with vasodilator therapy. Digital plethysmography established fixed ischemia within the fifth finger; subsequently, cilostazol was prescribed. Four weeks later the digital pain and cyanosis had essentially resolved. A follow-up plethysmographic waveform documented restored perfusion. Although approved for the treatment of intermittent claudication, cilostazol was successfully utilized in the setting of severe digital ischemia.
More Related Videos
05:26Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome IV: Interprofessional Care
Angina II: Classification
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care